Mesoblast
MESO
$6.15
Share price
-1.13%
Change (1 day)
83.04%
Change (1 year)
Categories
EPS for Mesoblast (MESO)
EPS in 2023 (TTM): $40.26
According to Mesoblast 's latest financial reports the company's current EPS (TTM) is $40.26. In 2022 the company made an earnings per share (EPS) of $36.51 an increase over its 2021 EPS that were of -$0.76.
EPS history for Mesoblast from 2015 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | $40.26 | 10.27% |
| 2022 | $36.51 | -4897.44% |
| 2021 | -$0.76 | -13.08% |
| 2020 | -$0.88 | 17.91% |
| 2019 | -$0.74 | -17.18% |
| 2018 | -$0.90 | 141.13% |
| 2017 | -$0.37 | 422.52% |
| 2016 | -$0.07115 | -94.58% |
| 2015 | -$1.31 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Nymox Pharmaceutical NYMX | -$0.06000 | -100.15% | Bahamas |
 NRC Health
NRC | $1.19 | -97.04% | 🇺🇸 USA |